↓ Skip to main content

The addition of rituximab to CHOP therapy alters the prognostic significance of CD44 expression

Overview of attention for article published in Journal of Hematology & Oncology, April 2014
Altmetric Badge

Readers on

mendeley
15 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The addition of rituximab to CHOP therapy alters the prognostic significance of CD44 expression
Published in
Journal of Hematology & Oncology, April 2014
DOI 10.1186/1756-8722-7-34
Pubmed ID
Authors

Xiaolei Wei, Meng Xu, Yongqiang Wei, Fen Huang, Tong Zhao, Xiangzhao Li, Ru Feng, B Hilda Ye

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 7%
United States 1 7%
Unknown 13 87%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 27%
Other 3 20%
Student > Ph. D. Student 3 20%
Professor 2 13%
Student > Bachelor 2 13%
Other 1 7%
Readers by discipline Count As %
Medicine and Dentistry 11 73%
Biochemistry, Genetics and Molecular Biology 2 13%
Business, Management and Accounting 1 7%
Chemical Engineering 1 7%